NYSE:GKOS
Glaukos Corporation Stock News
$109.79
-0.620 (-0.562%)
At Close: May 17, 2024
Glaukos Corporation Announces Proposed Private Offering of $200 Million of Convertible Senior Notes
11:06am, Monday, 08'th Jun 2020
Glaukos Corporation (NYSE: GKOS) (the "Company" or "Glaukos"), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders a
Glaukos (GKOS) Up 13.8% Since Last Earnings Report: Can It Continue?
03:31pm, Saturday, 06'th Jun 2020
Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Edited Transcript of GKOS earnings conference call or presentation 7-May-20 8:30pm GMT
03:19am, Thursday, 04'th Jun 2020
Q1 2020 Glaukos Corp Earnings Call
Glaukos Announces Participation in the William Blair 40th Annual Growth Stock Conference
08:30pm, Tuesday, 02'nd Jun 2020
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today an
Glaukos Announces Participation in the William Blair 40th Annual Growth Stock Conference
12:00am, Tuesday, 02'nd Jun 2020
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma
Dr. Gil Kliman and Tom Frinzi Appointed to STAAR Surgical Board of Directors
12:00am, Monday, 01'st Jun 2020
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announce
Glaukos (GKOS) Q1 2020 Earnings Call Transcript
03:01pm, Saturday, 09'th May 2020
Image source: The Motley Fool. Glaukos (NYSE: GKOS)Q1 2020 Earnings CallMay 07, 2020, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorWel
Edited Transcript of GKOS earnings conference call or presentation 7-May-20 8:30pm GMT
08:07pm, Friday, 08'th May 2020
Q1 2020 Glaukos Corp Earnings Call
Glaukos (GKOS) Q1 Earnings and Revenues Miss Estimates
12:50pm, Friday, 08'th May 2020
Glaukos (GKOS) witnessed a contraction in gross margin but year-over-year revenue surge in Q1.
U.S. RESEARCH ROUNDUP-Becton Dickinson, Epam Systems, PayPal Holdings
11:36am, Friday, 08'th May 2020
Wall Street securities analysts on Friday revised their ratings and price targets on several
U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings.
HIGHLIGHTS
Glaukos (GKOS) Reports Q1 Loss, Misses Revenue Estimates
12:40am, Friday, 08'th May 2020
Glaukos (GKOS) delivered earnings and revenue surprises of -25.71% and -0.10%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Glaukos Corporation Announces First Quarter 2020 Financial Results
08:10pm, Thursday, 07'th May 2020
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today an
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
